Tango Therapeutics, Inc. ($TNGX)
Crystal Adam โ President, R&D
Shares
27,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Crystal Adam |
|---|---|
| Title | President, R&D |
| Transaction Date | May 1, 2026 |
| Expiration Date | Mar 1, 2033 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | May 5, 2026 |
| Shares Purchased | 27,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 368,040 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-207096 |
| Document | View SEC Filing |